from China. The proportion of revenue from sales increase by Baht 65 million and as a result of the gross profit margin growth to 12%. Sales from selling food and beverages Revenue from sales increased
products from China. The proportion of revenue from sales increase by Baht 23 million and as a result of the gross profit margin growth to 16%. Sales from selling food and beverages Revenue from sales
overall sales volume, the Company and its subsidiaries brought 1.6% growth of Gross profit margin versus 2017 by the strong contribution of Epicerol® business. 2. In 2018, distribution costs, administrative
1Q2017, or a 83.3% growth YoY. EBITDA Margin improved from 65.1% in 1Q2017 to 74.4% in 1Q2018. Our Net Profit attributable to Owners of the Parent increased by 162.8% in 1Q2018, compared to 1Q2017 figures
101.48 million or 65.46%, which was in line with the sharp rising in revenues from sales in this period. Gross profit margin in year 2018 was 61.51%, going up by 59.98% year-on-year. The growth in year
in revenues from sales in this period. Gross profit margin in Q3/2018 was 63.46%, going up by 59.09% year-on-year. The growth in Q3/2018 gross profit margin was mainly driven by the adoption of
. However, the cost increase was at lower rate than revenue increase. Likewise, 4Q17 hospital cost increased by 10% yoy lower than revenue growth. As a result, gross margin improved to 30% in 2017 from 28
% 1,035.97 893.13 16% Cost of hospital operations 262.51 222.97 18% 727.34 640.28 14% Gross margin 127.66 94.76 35% 308.63 252.85 22% % Gross margin 33% 30% 3% 30% 28% 1% Administrative expenses 39.07 36.43 7
employees for their co-operation in achieving targets for revenue growth, store expansion, driving gross margin and good customer service, as well as having awareness on energy conservation and care for the
, AIS delivered a 4.1% core service revenue growth with 43.7% normalized EBITDA margin and has announced an interim dividend of Bt3. 78/ share, following minimum 70% payout ratio. The guidance for the